JP2010538282A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538282A5
JP2010538282A5 JP2010523316A JP2010523316A JP2010538282A5 JP 2010538282 A5 JP2010538282 A5 JP 2010538282A5 JP 2010523316 A JP2010523316 A JP 2010523316A JP 2010523316 A JP2010523316 A JP 2010523316A JP 2010538282 A5 JP2010538282 A5 JP 2010538282A5
Authority
JP
Japan
Prior art keywords
reg
psp
concentration
antibody
onset
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010523316A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538282A (ja
JP5048838B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/007158 external-priority patent/WO2009030456A1/en
Publication of JP2010538282A publication Critical patent/JP2010538282A/ja
Publication of JP2010538282A5 publication Critical patent/JP2010538282A5/ja
Application granted granted Critical
Publication of JP5048838B2 publication Critical patent/JP5048838B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010523316A 2007-09-07 2008-09-02 ヒト敗血症を測定する方法 Active JP5048838B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07017539.3 2007-09-07
EP07017539 2007-09-07
PCT/EP2008/007158 WO2009030456A1 (en) 2007-09-07 2008-09-02 Method for assaying sepsis in humans

Publications (3)

Publication Number Publication Date
JP2010538282A JP2010538282A (ja) 2010-12-09
JP2010538282A5 true JP2010538282A5 (enExample) 2011-10-20
JP5048838B2 JP5048838B2 (ja) 2012-10-17

Family

ID=40040164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523316A Active JP5048838B2 (ja) 2007-09-07 2008-09-02 ヒト敗血症を測定する方法

Country Status (13)

Country Link
US (2) US8435755B2 (enExample)
EP (1) EP2185937B2 (enExample)
JP (1) JP5048838B2 (enExample)
CN (1) CN101796418B (enExample)
AT (1) ATE514950T1 (enExample)
AU (1) AU2008295046B2 (enExample)
CA (1) CA2696319C (enExample)
DK (1) DK2185937T4 (enExample)
ES (1) ES2368877T5 (enExample)
NZ (1) NZ583474A (enExample)
PL (1) PL2185937T5 (enExample)
PT (1) PT2185937E (enExample)
WO (1) WO2009030456A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2577316T3 (en) * 2010-05-31 2017-05-08 Univ Hospital Of Basel Procedure for testing for lower respiratory tract infections or inflammation
WO2012028594A1 (en) 2010-08-31 2012-03-08 Otto-Von-Guericke-Universität Magdeburg Method for assaying peritonitis in humans
US20130004968A1 (en) * 2010-09-22 2013-01-03 Robert Webber Sepsis blood biomarker system
WO2014009480A1 (en) 2012-07-12 2014-01-16 Universität Zürich Method for assaying sepsis and outcome in humans by detection of psp/reg
WO2014068018A1 (en) * 2012-10-30 2014-05-08 Abbott Gmbh & Co.Kg Methods of prognosis and diagnosis of sepsis
WO2014117165A1 (en) * 2013-01-28 2014-07-31 Vanderbilt University Method for differentiating sepsis and systemic inflammatory response syndrome (sirs)
EP2813852A3 (en) 2013-06-11 2015-03-25 University Of Zurich Method for detecting the development of an infection in humans
CN106367488A (zh) * 2016-08-29 2017-02-01 北京泱深生物信息技术有限公司 Letmd1在脓毒症诊断中的应用
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
WO2019053118A1 (en) 2017-09-13 2019-03-21 B.R.A.H.M.S Gmbh PROADRÉNOMÉDULLINE AS A MARKER OF ABNORMAL PLATELET RATES
EP3502706A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
CN108181472B (zh) * 2018-03-05 2020-07-21 吉林大学 昆虫细胞表达psp为校准品的检测psp试剂盒
EP3578989A1 (en) * 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients
FR3087338B1 (fr) 2018-10-22 2020-10-09 Amadeite Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
CA3196464A1 (en) * 2020-11-03 2022-05-12 Nicolas Durand Method for assessing the severity of sars
US20250020663A1 (en) * 2021-11-25 2025-01-16 Abionic Sa Method for the management of antibiotic administration

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378924B1 (en) 1988-12-21 1996-11-13 The General Hospital Corporation Detection of neurological disease or dysfunction
GB9613629D0 (en) * 1996-06-28 1996-08-28 Univ Leeds Reg gene expression in cancer tissue
DE50105971D1 (de) * 2001-12-04 2005-05-25 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125
EP1318405B1 (de) 2001-12-04 2004-11-17 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
DE50103032D1 (de) 2001-12-04 2004-09-02 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 19-9
DE50103030D1 (de) 2001-12-04 2004-09-02 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von S100B
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
JP2004194534A (ja) * 2002-12-17 2004-07-15 Sumitomo Pharmaceut Co Ltd 炎症性腸疾患疾患マーカーおよびその利用
EP1581812B1 (en) * 2003-01-06 2008-07-16 Wyeth Compositions and methods for diagnosing and treating colon cancers
WO2004087874A2 (en) * 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
US20070224638A1 (en) 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
DK2577316T3 (en) * 2010-05-31 2017-05-08 Univ Hospital Of Basel Procedure for testing for lower respiratory tract infections or inflammation

Similar Documents

Publication Publication Date Title
JP2010538282A5 (enExample)
Wu et al. Portable GMR handheld platform for the detection of influenza A virus
Zhou et al. Sensitive sandwich ELISA based on a gold nanoparticle layer for cancer detection
Soelberg et al. Surface plasmon resonance detection using antibody-linked magnetic nanoparticles for analyte capture, purification, concentration, and signal amplification
US11523752B2 (en) Assay for vapor condensates
HRP20201840T1 (hr) Postupci za ocjenjivanje imunološkog odgovora na terapijsko sredstvo
JP2008524593A5 (enExample)
JP2014508298A5 (enExample)
Kumbhat et al. Surface plasmon resonance biosensor for dopamine using D3 dopamine receptor as a biorecognition molecule
JP2012509477A5 (enExample)
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
JP2015230280A5 (enExample)
BR112014018831B1 (pt) Método de formação de um sensor para um ou mais analitos
JP2013513113A5 (enExample)
Liu et al. Efficient molecular imprinting strategy for quantitative targeted proteomics of human transferrin receptor in depleted human serum
JP2013072663A5 (enExample)
EP2583101A1 (en) Multi epitope assay
EP2175272A3 (en) Reagents, kits and methods for detecting biological molecules by energy transfer from an activated chemiluminescent substrate to an energy acceptor dye
WO2006083367A3 (en) Immunoassay employing two-step internal calibration reaction
CN103278621A (zh) 一种利用生物传感器与血糖仪检测转录因子的方法
WO2011017436A3 (en) A high precision quantitative assay composition and methods of use therefor
CN110095592A (zh) 一种c反应蛋白单膜检测干片
CN104614498A (zh) 食品中致病菌检测的巨磁阻抗效应生物传感器
CN104849443B (zh) 基于pH计的酶联免疫吸附测定方法
Wei et al. Label-free detection of pepsinogen 1 and 2 by polyethylene coating Lamb microfluidic device